Clinical Trials Directory

Trials / Unknown

UnknownNCT02244515

Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Jin Ni · Academic / Other
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether dexmedetomidine is effective in the treatment of emergence deliruim after sevoflurane anesthesia in children with cerebral palsy.

Conditions

Interventions

TypeNameDescription
DRUGdexmedetomidinedexmedetomidine 0.5μg•kg-1 diluted in 10 ml NaCI 0.9%

Timeline

Start date
2014-06-01
Primary completion
2014-09-01
First posted
2014-09-19
Last updated
2014-09-19

Source: ClinicalTrials.gov record NCT02244515. Inclusion in this directory is not an endorsement.

Consequence of Dexmedetomidine on Emergence Deliruim After Sevoflurane Anesthesia in Children With Cerebral Palsy (NCT02244515) · Clinical Trials Directory